Redensyl
Also known as: DHQG + EGCG2 blend, Induchem
Limited EvidenceProprietary BlendAndrogenic Alopecia
Patented blend targeting hair follicle stem cells, marketed as a minoxidil alternative.
Regrowth Potential20%
Long-Term Viability45%
Mechanism of Action
Redensyl contains dihydroquercetin-glucoside (DHQG), which targets hair follicle stem cells (outer root sheath cells) and activates them via the Wnt pathway, and EGCG-glucoside (EGCG2), which stimulates dermal papilla cell metabolism. Together they aim to reactivate dormant follicles and shift hair cycling toward anagen.
Unlock Premium Content
Get full access to in-depth analyses, cited studies, premium articles, and AI chat.
$12/mo
View pricing